PENHOET EDWARD

Insider CIK 1198332 · NONE Director · SCYX Director · AEGR 10% owner · CCXI Director · CARA 10% owner · IMDZ Director, 10% owner

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
IMDZ IMMUNE DESIGN CORP.	D To issuer deriv	2019-04-02	2019-04-04	3,058	—	$0	0	SEC↗
IMDZ IMMUNE DESIGN CORP.	D To issuer deriv	2019-04-02	2019-04-04	4,281	—	$0	0	SEC↗
IMDZ IMMUNE DESIGN CORP.	D To issuer deriv	2019-04-02	2019-04-04	10,000	—	$0	0	SEC↗
IMDZ IMMUNE DESIGN CORP.	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
IMDZ IMMUNE DESIGN CORP.	D To issuer deriv	2019-04-02	2019-04-04	12,500	—	$0	0	SEC↗
IMDZ IMMUNE DESIGN CORP.	A Award deriv	2019-01-03	2019-01-07	12,500	—	$0	12,500	SEC↗
IMDZ Immune Design Corp.	A Award deriv	2018-01-04	2018-01-08	12,500	—	$0	12,500	SEC↗
IMDZ Immune Design Corp.	A Award deriv	2017-01-04	2017-01-06	10,000	—	$0	10,000	SEC↗
IMDZ Immune Design Corp.	A Award deriv	2016-01-04	2016-01-06	9,300	—	$0	9,300	SEC↗
SCYX SCYNEXIS INC	A Award deriv	2015-06-04	2015-06-05	8,800	—	$0	8,800	SEC↗
CBAY CymaBay Therapeutics, Inc.	A Award deriv	2015-01-07	2015-01-08	9,000	—	$0	9,000	SEC↗
IMDZ Immune Design Corp.	A Award deriv	2015-01-07	2015-01-09	9,300	—	$0	9,300	SEC↗
IMDZ Immune Design Corp.	C Conversion deriv	2014-07-29	2014-07-31	611,620	—	$0	0	SEC↗
IMDZ Immune Design Corp.	X Exercise deriv	2014-07-29	2014-07-31	305,810	—	$0	305,810	SEC↗
IMDZ Immune Design Corp.	X Exercise deriv	2014-07-29	2014-07-31	305,810	—	$0	0	SEC↗
IMDZ Immune Design Corp.	C Conversion deriv	2014-07-29	2014-07-31	305,810	—	$0	0	SEC↗
IMDZ Immune Design Corp.	C Conversion deriv	2014-07-29	2014-07-31	531,843	—	$0	0	SEC↗
IMDZ Immune Design Corp.	C Conversion deriv	2014-07-29	2014-07-31	733,943	—	$0	0	SEC↗
IMDZ Immune Design Corp.	C Conversion	2014-07-29	2014-07-31	611,620	—	$0	1,877,406	SEC↗
IMDZ Immune Design Corp.	C Conversion	2014-07-29	2014-07-31	733,943	—	$0	733,943	SEC↗
IMDZ Immune Design Corp.	P Buy	2014-07-29	2014-07-31	299,559	$12.00	$3.59M	2,482,775	SEC↗
IMDZ Immune Design Corp.	C Conversion	2014-07-29	2014-07-31	305,810	—	$0	2,183,216	SEC↗
IMDZ Immune Design Corp.	C Conversion	2014-07-29	2014-07-31	531,843	—	$0	1,265,786	SEC↗
SCYX SCYNEXIS INC	A Award deriv	2014-06-11	2014-06-13	3,480	—	$0	3,480	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion deriv	2014-02-05	2014-02-05	89,227	—	$0	0	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion deriv	2014-02-05	2014-02-05	1,328,604	—	$0	0	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion deriv	2014-02-05	2014-02-05	32,742	—	$0	0	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion deriv	2014-02-05	2014-02-05	158,741	—	$0	0	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion deriv	2014-02-05	2014-02-05	2,363,654	—	$0	0	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion deriv	2014-02-05	2014-02-05	58,250	—	$0	0	SEC↗
CARA Cara Therapeutics, Inc.	P Buy	2014-02-05	2014-02-05	6,940	$11.00	$76.3K	117,760	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion	2014-02-05	2014-02-05	1,118,675	—	$0	1,118,675	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion	2014-02-05	2014-02-05	531,442	—	$0	1,650,117	SEC↗
CARA Cara Therapeutics, Inc.	P Buy	2014-02-05	2014-02-05	103,330	$11.00	$1.14M	1,753,447	SEC↗
CARA Cara Therapeutics, Inc.	P Buy	2014-02-05	2014-02-05	2,547	$11.00	$28.0K	43,212	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion	2014-02-05	2014-02-05	13,097	—	$0	40,665	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion	2014-02-05	2014-02-05	27,568	—	$0	27,568	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion	2014-02-05	2014-02-05	35,691	—	$0	110,820	SEC↗
CARA Cara Therapeutics, Inc.	C Conversion	2014-02-05	2014-02-05	75,129	—	$0	75,129	SEC↗
NONE CymaBay Therapeutics, Inc.	A Award deriv	2014-01-06	2014-01-08	2,870	—	$0	2,870	SEC↗
NONE CymaBay Therapeutics, Inc.	A Award deriv	2013-12-23	2014-01-15	2,335	—	$0	2,335	SEC↗
NONE CymaBay Therapeutics, Inc.	A Award deriv	2013-10-31	2013-11-01	6,470	—	$0	6,470	SEC↗
CCXI ChemoCentryx, Inc.	A Award deriv	2013-05-23	2013-05-24	12,500	—	$0	12,500	SEC↗
AEGR Aegerion Pharmaceuticals,	S Sale	2012-10-16	2012-10-17	3,160	$18.67	$59.0K	56,190	SEC↗
AEGR Aegerion Pharmaceuticals,	S Sale	2012-10-16	2012-10-17	128,229	$18.67	$2.39M	2,280,197	SEC↗
AEGR Aegerion Pharmaceuticals,	S Sale	2012-10-16	2012-10-17	8,611	$18.67	$160.8K	153,131	SEC↗
AEGR Aegerion Pharmaceuticals,	S Sale	2012-10-15	2012-10-17	1,371	$17.54	$24.0K	59,350	SEC↗
AEGR Aegerion Pharmaceuticals,	S Sale	2012-10-15	2012-10-17	55,626	$17.54	$975.7K	2,408,426	SEC↗
AEGR Aegerion Pharmaceuticals,	S Sale	2012-10-15	2012-10-17	3,736	$17.54	$65.5K	161,742	SEC↗
CCXI ChemoCentryx, Inc.	A Award deriv	2012-06-22	2012-06-26	12,500	—	$0	12,500	SEC↗
CCXI ChemoCentryx, Inc.	C Conversion deriv	2012-02-13	2012-02-15	73,793	—	$0	0	SEC↗
CCXI ChemoCentryx, Inc.	C Conversion deriv	2012-02-13	2012-02-15	427,683	—	$0	0	SEC↗
CCXI ChemoCentryx, Inc.	C Conversion deriv	2012-02-13	2012-02-15	10,540	—	$0	0	SEC↗
CCXI ChemoCentryx, Inc.	C Conversion deriv	2012-02-13	2012-02-15	28,723	—	$0	0	SEC↗
CCXI ChemoCentryx, Inc.	C Conversion deriv	2012-02-13	2012-02-15	201,097	—	$0	0	SEC↗
CCXI ChemoCentryx, Inc.	C Conversion deriv	2012-02-13	2012-02-15	2,994,341	—	$0	0	SEC↗
CCXI ChemoCentryx, Inc.	C Conversion	2012-02-13	2012-02-15	1,711,012	—	$0	1,825,922	SEC↗
CCXI ChemoCentryx, Inc.	C Conversion	2012-02-13	2012-02-15	42,166	—	$0	1,868,088	SEC↗
CCXI ChemoCentryx, Inc.	C Conversion	2012-02-13	2012-02-15	114,910	—	$0	114,910	SEC↗